Australian Research Council (ARC) Training Centre for Cell and Tissue Engineering Technologies (CTET)
CTET is led by Monash University in collaboration with the Queensland University of Technology and 22 partner organisations.
CTET brings together targeted research and industry-specific training to develop future-ready leaders in regenerative medicine and advanced biomanufacturing.
Funding from the ARC enables this Centre to foster deep university–industry collaboration in a high-growth sector, delivering significant health and economic benefits for Australia.
About
Australia’s cell-based and tissue engineering sector is undergoing significant growth, lead primarily by small to medium enterprises.
Currently, there are around 100 companies operating in tissue engineering, regenerative medicine, and cell therapy — a number that is expected to increase as the sector matures.
These companies are now shifting from proof-of-principle studies to clinical validation, regulatory approval, and commercial standardisation. This transition marks a pivotal stage in the development of advanced therapies and the future of healthcare innovation.
However, the pace of growth is limited by a shortage of graduates who possess the right combination of scientific expertise, entrepreneurial thinking, and commercial insight.
CTET is responding to this challenge. We are aligning with industry to support Australia’s MedTech, Pharma, and Advanced Manufacturing Industry Growth Priorities. Through targeted training programs and applied research, CTET is building a highly skilled, future-ready workforce and delivering innovative technology solutions across these high-impact sectors.
Our mission
To train a highly skilled, entrepreneurial, industry-ready workforce that is poised to consolidate the growing industry base of the tissue engineering and regenerative medicine sector and translate innovative technologies into commercialisation.
To develop technology solutions to advanced manufacturing, process efficiencies, monitoring and costs of goods along the product value chain, as well as new business models and approaches, which will elevate the delivery of these promising treatments for eventual health benefits.
To foster collaboration between academia and industry along the value chain for the tissue engineering and regenerative medicine sector.
To help companies accelerate delivery of real-world solutions in tissue engineering and regenerative medicine to the national and global market.
Our partners
CTET’s partnerships are foundational to its impact.
Located in the Monash Innovation Precinct, CTET benefits from proximity to leading national facilities and research hubs. Through active collaboration with CSIRO Manufacturing, ARMI, the Melbourne Centre for Nanofabrication, and Monash Health Translational Precinct, we ensure seamless integration of research, translation, and clinical pathways.
Our international collaborations with globally respected institutions such as the Canadian Centre for Regenerative Medicine, the UK’s Cell and Gene Therapy Catapult, and the Leibniz Institute of Polymer Research Dresden expand our global reach and research excellence.
CTET also partners with a diverse range of industry organisations across biotechnology, medical technologies, and advanced manufacturing, ensuring our research is aligned with market needs and poised for real-world application.
